Evaluating Auscul-X, a Touch Free Digital Stethoscope

NCT04570189 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-12-14

No results posted yet for this study

Summary

Auscul-X a touch free digital stethoscope will permit physical distancing of healthcare providers while maintaining the ability to auscultate patients from a safe distance (over 10 feet away)

Conditions

Interventions

DEVICE

Auscul-X

The Auscul-X System (AusculSciences Canada, Inc.), is novel, professional grade, touch free, multichannel, touch-free electronic stethoscope with disposable elements designed to protect HCPs from exposure to infection diseases by allowing them to auscultate patients from a safe distance (10 feet away). The sensors can stay in place and enable providers to listen on-demand to a patient's heart and lungs over an extended period of time. This practice of distancing in the workplace is a key CDC and PHAC recommendation to protect the frontline HCP from exposure risk to the highly contagious COVID- 19 virus and other communicable diseases. The Auscul-X not only has the potential to better protect HCPs from infection, but also eliminates the potential transmission of pathogens through the use of conventional stethoscopes. In addition, the Auscul-X allows multiple HCPs to listen to the patient's heart and lung sounds simultaneously

Sponsors & Collaborators

  • Ottawa Heart Institute Research Corporation

    collaborator OTHER
  • AusculSciences Canada Inc.

    lead INDUSTRY

Principal Investigators

  • Benjamin Chow, MD · Ottawa Heart Institue Research Foundation

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570189 on ClinicalTrials.gov